Table 3.

Prognostic analysis of KNSTRN expression in a subset of patients with LUAD.

Characteristics	N (%)	Hazard ratio	P value
T stage
T1	168 (34)	1.710 (0.938-3.117)	0.080
T2	269 (54)	1.368 (0.925-2.022)	0.116
T3	45 (9)	2.930 (1.166-7.363)	0.022
N stage
N0	325 (66)	1.814 (1.183-2.780)	0.006
N1	94 (19)	1.184 (0.687-2.039)	0.543
N2	71 (14)	1.528 (0.757-3.086)	0.237
M stage
M0	335 (93)	1.713 (1.201-2.444)	0.003
Clinical stage
Stage I	270 (54)	1.730 (1.062-2.817)	0.028
Stage II	119 (24)	1.038 (0.606-1.778)	0.892
Stage III	81 (16)	1.475 (0.768-2.831)	0.243
Age
< 65	220 (45)	1.544 (0.963-2.477)	0.071
>= 65	274 (55)	2.104 (1.428-3.098)	<0.001
Gender
Female	270 (54)	1.531 (1.023-2.291)	0.038
Male	234 (46)	1.938 (1.232-3.047)	0.004
Anatomic subdivision
Left	194 (40)	1.886 (1.183-3.008)	0.008
Right	296 (60)	1.600 (1.078-2.373)	0.020
Smoking status
Non-smoker	71 (14)	1.219 (0.556-2.673)	0.620
Smoker	419 (86)	1.833 (1.311-2.564)	<0.001